Generic Name: olaratumab
Applies to olaratumab: intravenous solution
Get emergency medical help if you have signs of an allergic reaction:  hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Some side effects may occur during the injection.  Tell your caregiver right away if you feel dizzy, light-headed, chilled, flushed, feverish, or short of breath, or if you have a cold sweat, chest tightness, or trouble breathing.
Call your doctor at once if you have:
sores or white patches in or around your mouth, trouble swallowing or talking, dry mouth, bad breath, altered sense of taste;
easy bruising, unusual bleeding (nose, mouth, vagina, or rectum), purple or red pinpoint spots under your skin;
fever, cough, cold or flu symptoms;
swollen gums;
skin sores; or
trouble breathing.
Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.
Common side effects may include:
nausea, vomiting, stomach pain, diarrhea, loss of appetite;
feeling tired;
muscle or joint pain;
numbness, weakness, or pain in your hands or feet;
hair loss; or
headache.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. 
Applies to olaratumab: intravenous solution
The most common (20% or greater) adverse reactions of this drug plus doxorubicin are nausea, fatigue, musculoskeletal pain, mucositis, alopecia, vomiting, diarrhea, decreased appetite, abdominal pain, neuropathy, and headache.[Ref]
Very common (10% or more): Alopecia (up to 52%)[Ref]
Very common (10% or more): Nausea (up to 73%), mucositis (up to 53%), vomiting (up to 45%), diarrhea (up to 34%), abdominal pain upper/lower (up to 23%)
Very common (10% or more): Lymphopenia (up to 77%), neutropenia (up to 65%), thrombocytopenia (up to 63%), elevated activated partial thromboplastin time (aPTT) (33%)[Ref]
Common (1% to 10%): Treatment emergent immunogenicity[Ref]
Very common (10% or more): Hyperglycemia (up to 52%), appetite decreased (up to 31%), hypokalemia (up to 21%), hypophosphatemia (up to 21%), alkaline phosphatase increased (16%), hypomagnesemia (up to 16%)[Ref]
Very common (10% or more): Musculoskeletal pain (i.e., arthralgia, back pain, bone pain, flank pain, groin pain, musculoskeletal chest pain, myalgia, muscle spasms, neck pain, pain in extremity) (up to 64%)[Ref]
Very common (10% or more): Neuropathy (up to 22%), headache (up to 20%)[Ref]
Very common (10% or more): Dry eyes (up to 11%)[Ref]
Very common (10% or more): Fatigue/asthenia (up to 69%), flushing, fever/chills (up to 14%)[Ref]
Very common (10% or more): Anxiety (up to 11%)[Ref]
Very common (10% or more): Shortness of breath, bronchospasm[Ref]
Frequency not reported: Anaphylactic shock[Ref]
Frequency not reported: Severe hypotension, cardiac arrest[Ref]
1. "Product Information. Lartruvo (olaratumab)." Lilly, Eli and Company, Indianapolis, IN. 
Not all side effects for Lartruvo may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.


sores or white patches in or around your mouth, trouble swallowing or talking, dry mouth, bad breath, altered sense of taste;


easy bruising, unusual bleeding (nose, mouth, vagina, or rectum), purple or red pinpoint spots under your skin;


fever, cough, cold or flu symptoms;


swollen gums;


skin sores; or


trouble breathing.




nausea, vomiting, stomach pain, diarrhea, loss of appetite;


feeling tired;


muscle or joint pain;


numbness, weakness, or pain in your hands or feet;


hair loss; or


headache.


